Phase 3 Papulopustular Rosacea Study

NCT01494467 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

688

Enrollment

INDUSTRY

Sponsor class

Conditions

Papulopustular Rosacea

Interventions

DRUG: CD5024
DRUG: Azelaic acid 15% Gel

Sponsor

Galderma R&D